Research Abstract
* Development of DNA technologies for assessing the impact of rare mutations in cancer management
* Development and detection of patient specific biomarkers for cancer prognosis and individual response to therapy. Detection of rare mutations in blood and other bodily fluids via liquid biopsy
* Development of nano-technology-based approaches to improving the therapeutic ratio in radiation therapy
* Radiation dosimetry and dosimetry at the cellular level